Early encounter of microbes and fetal immune system during second trimester of gestation eurekalert.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from eurekalert.org Daily Mail and Mail on Sunday newspapers.
Sidra Medicine World’s first WPA Collaborating Center for women, children
07 May 2021 - 11:36
The Peninsula
Sidra Medicine’s Department of Psychiatry has been designated as a Collaborating Center of the World Psychiatric Association (WPA) for child and adolescent psychiatry and in maternal and perinatal mental health.
The WPA is a global organization representing 145 psychiatric societies in 121 countries and promotes collaborative work in psychiatry. WPA collaborating centers are institutions that have national, regional and international recognition as leaders in clinical care, research and teaching. “I would like to congratulate Sidra Medicine for receiving this prestigious designation as a WPA Collaborating Center”, said Professor Afzal Javed, President of the World Psychiatric Association.
By: Times News Service
Muscat: The Oman Medical Speciality Board (OMSB) has started discussions to update the organisational structure of the board.
A statement issued online by the Oman News Agency (ONA) said, “The Board of Trustees of the OMSB discusses, during its second meeting this year, updating the organisational structure of the board, the report of the General Foundation Program work team and the institutional accreditation reports of the Board from the Accreditation Council for Graduate Medical Education International(ACGME-I).
Credit: A STAR s Genome Institute of Singapore (GIS)
22 December 2020, Singapore - For over 20 years, the Genetics Service at the KK Women s and Children s Hospital (KKH) has been providing clinical care to patients with genetic
disorders. In 2014, BRIDGES (Bringing Research Innovations for the Diagnosis of GEnetic diseases in Singapore) was set up, in collaboration with genomic research institutes at SingHealth, Agency for Science, Technology and Research (A STAR) and Duke-NUS to synergise the diagnostic efforts and patient outcome management.
After six years, the KKH has met the goals set out in its BRIDGES programme, achieving 39 per cent in diagnostic yield through identifying more patients with genetic mutations. This result is on par with similar research programmes globally which have a diagnostic yield of 25 to 40 per cent.